Sort   by:  
 Page size 
UnknownHealthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach.
Not available
S-EPMC7194165 | biostudies-literature
UnknownPrevalence of hematopoietic cell transplant survivors in the United States.
Not available
S-EPMC3779514 | biostudies-literature
UnknownSignificant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era.
Not available
S-EPMC4272902 | biostudies-literature
UnknownSurvival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.
Not available
S-EPMC4019683 | biostudies-literature
UnknownVenous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis.
Not available
S-EPMC7453956 | biostudies-literature
UnknownFinancial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study.
Not available
S-EPMC5014617 | biostudies-literature
UnknownThe risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis.
Not available
S-EPMC7390725 | biostudies-literature
UnknownEasy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.
Not available
S-EPMC6193865 | biostudies-literature
UnknownComparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.
Not available
S-EPMC4568172 | biostudies-literature
UnknownOutcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
Not available
S-EPMC5030817 | biostudies-literature
Sort   by:  
 Page size